United Kingdom

People: Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

4:50pm BST
Change (% chg)

-11.40 (-3.17%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Durand, Jannie 

Mr. Jannie Jonathan (Jan) Durand is Non-Executive Director of Mediclinic International Plc., since 15 February 2016. Prior to the combination of the businesses of the Company (then Al Noor Hospitals Group plc) and Mediclinic International Limited in 2016, he served as a non-executive director of Mediclinic International Limited from 2012. He joined the Rembrandt group in 1996 and was appointed as the Chief Executive Officer of Remgro Limited in 2012, which holds a 44.56% interest in the Company. In his current role, with more than 20 years’ experience in the investment industry, he acts as a non-executive director of various companies, including Distell Group Limited, FirstRand Limited, RCL Foods Limited and RMI Holdings Limited. Qualifications: Mr Durand holds an Honours degree in Accountancy from the University of Stellenbosch (B.Acc. (Hons)); a Master’s of Philosophy in Management Studies from Oxford University (M.Phil. (Management Studies)); and is a qualified Chartered Accountant with the South African Institute of Chartered Accountants. Mr Pieter Uys, the Head of Strategic Investment at Remgro Limited, is appointed as the alternate to Mr Durand since 7 April 2016. Prior to joining Remgro, Mr Uys was a founding member and ultimately became the Chief Executive Officer of the Vodacom group, one of the leading mobile networks in Africa. Qualifications: Mr Uys holds an M.Eng. (Electrical) degree; and an MBA from the University of Stellenbosch.

Basic Compensation

Total Annual Compensation, GBP 66,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 2,000
Fiscal Year Total, GBP 68,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --